why choose us

Clinical Trials Search

Showing 17,250 of 132,963 result(s)
Bioequivalence Study of Test and Reference 400 mg Ibuprofen Coated Tablets in Healthy Volunteers

Status: Completed

Condition: Randomized, Two-way, Two-period, Single Oral Dose, Open-label, Crossover, Bioequivalence Study to Co

Interventions: Interventional

Date: 2022-12-15

Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers

Status: Completed

Condition: Randomized, Two-way, Two-period, Single Oral Dose, Open-label, Crossover, Bioequivalence Study to Co

Interventions: Interventional

Date: 2022-12-15

Efficacy and Safety of Infliximab Biosimilar in Treatment of Resistant Hidradenitis Suppurativa

Status: Active, not recruiting

Condition: Hidradenitis Suppurativa

Interventions: Interventional

Date: 2022-12-15

A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Status: Active, not recruiting

Condition: Human Papillomavirus Infection

Interventions: Interventional

Date: 2022-12-15

Effect of Intraoperative Allogeneic Blood Transfusion on Postoperative Pulmonary Complications

Status: Completed

Condition: Spinal Fusion
Transfusion
Pulmonary Complication

Interventions: Procedure: transfusion
transfusion

Date: 2022-12-15

Efficacy and Safety of Ambervin® and Standard Therapy in Hospitalized Patients With COVID-19

Status: Completed

Condition: COVID-19

Interventions: Interventional

Date: 2022-12-15

Autonomic Effects of Stimulation in SCI

Status: Completed

Condition: Spinal Cord Injury

Interventions: transcutaneous stimulation of the spinal cord.

Date: 2022-12-15

Phase 1b;2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

Status: Completed

Condition: Advanced Cancer

Interventions: Given by IV (vein)

Date: 2022-12-15

A Repository to Study Host-Microbiome Interactions in Health and Disease

Status: Completed

Condition: Healthy Controls

Interventions:

Date: 2022-12-15

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Status: Completed

Condition: Non-muscle-invasive Bladder Cancer

Interventions: STM-416 monotherapy

Date: 2022-12-15